Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals Announces Pending Delisting from NASDAQ
November 21st, 2008
Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced that the Company elected not to appeal the NASDAQ Stock Market's Staff determination to delist Accentia's shares of common stock from the NASDAQ Capital Market. As previously reported, Accentia received notice from the NASDAQ Stock Market dated October 24, 2008, notifying the Company that it is not in compliance with Rule 4310(c)(3)(B), requiring a minimum $35 million market value. As a result, at the opening of business on November 4, 2008, shares of Accentia will open for trading listed on the Pink Sheets, an electronic quotation service for securities traded over-the-counter. Accentia's stock ticker symbol will remain the same...
Source: Health Business Week (2008-11-21)
|
